ENA Respiratory doses first participants in phase...
Category : Clinical Trial Update 2 February 2026"ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enh...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; th...
Category : Approval/Launch 2 February 2026"Tenpoint Therapeutics Ltd, a global and commercial biotechnology company focused on developing...
Almirall’s Seysara receives China NMPA approval fo...
Category : Approval/Launch 2 February 2026"Almirall, S.A, a global pharmaceutical company dedicated to medical dermatology announced that...
Boehringer Ingelheim Reports Positive Phase II Res...
Category : Clinical Trial Update 30 January 2026Boehringer Ingelheim has reported positive results from a 12-week Phase II clinical trial evaluating...
Innovative Molecules Advances Adibelivir into Phas...
Category : Clinical Trial Update 30 January 2026Innovative Molecules GmbH, a German clinical-stage biotech company, has completed its Phase 1 clinic...
Latest Newsletter Post
-
Almirall’s Seysara receives China N..
2 February 2026
-
Tenpoint Therapeutics’ Yuvezzi gets..
2 February 2026
-
ENA Respiratory doses first partici..
2 February 2026
-
FDA Clears MicuRx IND for MRX-5 to..
30 January 2026
-
Innovative Molecules Advances Adibe..
30 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com